Compound Monograph
Picrocrocin
Picrocrocin is the monoterpene glycoside behind saffron's bitter taste and the second-most-abundant compound in the dried stigma. Its main significance is as the precursor of safranal — the aroma compound released when it is hydrolysed during drying — and as a quality and authenticity marker for saffron.
Sources · 1
Where Does It Come From?
Picrocrocin is a naturally occurring monoterpene glycoside (apocarotenoid glucoside), found in Saffron. It is well tolerated orally (low toxicity).
Concentration
Content by Source
Reported concentrations across the plants that contain picrocrocin — the bar marks the typical level, the line shows the reported range.
Literature figures for varying plant parts and preparations. Read them as a comparative guide, not exact assays.
Picrocrocin at a Glance
Picrocrocin is a monoterpene glycoside and the compound responsible for the bitter taste of saffron (Crocus sativus). After the crocins, it is the second-most-abundant constituent of the dried stigma 11Reference 11Effective Isolation of Picrocrocin and Crocins from Saffron: From HPTLC to Working Standard ObtainingView study →.
Its importance is chiefly chemical and culinary rather than pharmacological. On drying and heating, picrocrocin is hydrolysed to release safranal — saffron’s principal aroma compound — plus glucose, so it effectively governs how saffron’s smell develops during processing 3,
As a bioactive molecule in its own right, picrocrocin is much less characterised than the crocin, crocetin and safranal it accompanies. What isolated-compound data exist are in-vitro only — antiproliferative and lipid-modulating signals in cell lines — with no clinical evidence. This page is deliberately lean, and honest about how far the evidence goes.
Saffron’s Bitter Principle & Safranal Precursor
This is the point of the molecule, and the reason it matters.
The bitter principle. Picrocrocin is what makes raw saffron taste bitter. Sensory-threshold work puts its detection threshold at 5.34 mg/L and its recognition threshold at 7.26 mg/L in water, with the bitterness falling when the solution is served hot and rising in dilute (40% v/v) aqueous ethanol 2Reference 2Sensory Threshold Studies of Picrocrocin, the Major Bitter Compound of SaffronView study →. Its name records this directly — pikros, Greek for “bitter”, prefixed to crocin.
The safranal precursor. Picrocrocin is the glycoside precursor of safranal. During drying, storage and cooking a β-glucosidase (and, more slowly, heat) cleaves off its glucose to give the aglycone HTCC (4-hydroxy-2,6,6-trimethylcyclohex-1-ene-1-carbaldehyde), which then dehydrates to the volatile aldehyde safranal 3,
The quality marker. Because the bitterness tracks picrocrocin, the international saffron standard ISO 3632 grades the spice partly on a “bitterness” reading — the specific absorbance (E¹%₁cm) at 257 nm, the wavelength of picrocrocin’s chromophore — alongside colouring strength (crocins, ~440 nm) and aroma (safranal) 5Reference 5Picrocrocin content and quality categories in different worldwide samples of saffron (Crocus sativus L.)View study →. Picrocrocin quantification is therefore central to authenticity testing and to detecting cheaper adulterants 5,
What It's Used For
Picrocrocin’s pharmacology is thin and entirely preclinical. The molecule is well studied as a flavour and quality marker, but as a bioactive it rests on a handful of in-vitro reports on the isolated compound or picrocrocin-enriched fractions.
Support is an experimental score — weighted by study type (human > animal > in vitro) and volume. A beta, not a validated metric. Note that the strongest row here is a flavour/quality role, not a medical one; the bioactivity rows are in-vitro isolate data.
The genuinely well-evidenced role, and the one it is built around. Picrocrocin is the isolated molecule responsible for saffron’s bitterness — thresholds of 5.34 mg/L (detection) and 7.26 mg/L (recognition) are established for the pure compound 2Reference 2Sensory Threshold Studies of Picrocrocin, the Major Bitter Compound of SaffronView study → — and the glycosidic precursor of safranal, releasing the aroma aldehyde plus glucose on enzymatic/thermal hydrolysis 3,
It is one of the three apocarotenoids ISO 3632 uses to grade and authenticate saffron, read as absorbance at 257 nm 5,
Gap: this is food chemistry and analytics, not a health claim — it describes what picrocrocin does to flavour and how it is measured, and says nothing about any therapeutic effect.
Isolated picrocrocin slowed the growth of SKMEL-2 human melanoma cells (reported IC50 ~20 μM), with the authors describing cell-cycle arrest, raised reactive oxygen species, loss of mitochondrial membrane potential and apoptosis via JAK/STAT5 signalling 6Reference 6Picrocrocin exhibits growth inhibitory effects against SKMEL-2 human malignant melanoma cells by targeting JAK/STAT5 signaling pathway, cell cycle arrest and mitochondrial mediated apoptosisView study →; a separate transport study found it suppressed proliferation of human adenocarcinoma and hepatocarcinoma lines, though it did not protect blood cells from oxidant-induced DNA damage at the concentration tested 1Reference 1Cellular Transport and Bioactivity of a Major Saffron Apocarotenoid, PicrocrocinView study →.
Gap: this is isolated compound in cell culture only — no animal or human data, one of the cancer reports is in a low-visibility journal, and picrocrocin’s minimal intact absorption (see Pharmacokinetics) makes the in-vivo relevance of micromolar cell-line potency uncertain.
A picrocrocin-enriched fraction from a saffron extract lowered lipid accumulation in HepG2 liver cells, altering the expression of key lipid-metabolism enzymes through a mechanism the authors describe as “non-statin-like” 7Reference 7A Picrocrocin-Enriched Fraction from a Saffron Extract Affects Lipid Homeostasis in HepG2 Cells through a Non-Statin-like ModeView study →.
Gap: the active agent was a picrocrocin-enriched fraction, not the pure molecule, in a single hepatocyte model — so the effect cannot be cleanly attributed to picrocrocin alone, and there is no whole-organism or clinical follow-up 7Reference 7A Picrocrocin-Enriched Fraction from a Saffron Extract Affects Lipid Homeostasis in HepG2 Cells through a Non-Statin-like ModeView study →.
Mechanisms
| Target / pathway | Effect | Relevant to |
|---|---|---|
| Bitter taste perception | drives saffron’s bitterness (specific receptor not identified in the cited work) | flavour / quality marker |
| β-glucosidase / thermal hydrolysis | cleaves glucose → HTCC aglycone → dehydrates to safranal | aroma development / safranal precursor |
| JAK/STAT5; cell cycle; mitochondria/ROS | growth inhibition and apoptosis in melanoma cells (in vitro) | antiproliferative |
| Lipid-metabolism enzyme expression | reduced lipid accumulation, non-statin-like (enriched fraction) | lipid metabolism |
| calf-thymus DNA | weak non-intercalative / minor-groove binding at lower concentrations than safranal | mechanistic (in vitro)no functional outcome |
The load-bearing mechanism is the bottom-of-the-page one: β-glucosidase hydrolysis to safranal. The cell-signalling rows are single-study, isolate-in-vitro observations.
Pharmacokinetics
The most useful pharmacokinetic point is a limiting one. In a Caco-2 intestinal-cell model, picrocrocin was highly bioaccessible (~75%) but barely transported across the intestinal barrier — on the order of 0.2%, roughly ten-fold lower than crocetin 1Reference 1Cellular Transport and Bioactivity of a Major Saffron Apocarotenoid, PicrocrocinView study →. In practical terms picrocrocin is liberated and available in the gut lumen but poorly absorbed intact, which undercuts read-across from micromolar cell-line potency to systemic effect. There are no human pharmacokinetic data for isolated picrocrocin; much of its ingested load is presumably hydrolysed (to safranal/HTCC and glucose) or metabolised by gut flora rather than absorbed whole.
Clinical Trials
There are no clinical trials of isolated picrocrocin for any indication. Saffron’s human trial record (depression, anxiety, metabolic and ocular endpoints) is built on standardised whole-stigma extracts and is attributed to the crocins, crocetin and safranal — picrocrocin’s specific contribution has not been isolated in any human study.
| Completed | Planned | Terminated | Preclinical |
|---|---|---|---|
| None(isolated picrocrocin) | — | — | Antiproliferative (melanoma, adenocarcinoma) + lipid-metabolism cell studies 1, |
Last checked: July 2026.
Isolate vs. Plant Studies
Picrocrocin sits at the isolated end for chemistry and the whole-plant end for any health relevance. Its analytical and sensory data use the pure compound — thresholds, safranal-conversion kinetics and ISO markers are all measured on isolated picrocrocin, a genuine strength for the flavour/quality story 2,
Its Role in Plants
Picrocrocin is a product of apocarotenoid biosynthesis in the saffron stigma. The carotenoid zeaxanthin is cleaved by a carotenoid cleavage dioxygenase (CsCCD2) to yield crocetin dialdehyde (the route to the crocins) and a C10 hydroxy-aldehyde, HTCC; the glycosyltransferase UGT709G1 then adds glucose to HTCC to form picrocrocin 3Reference 3UGT709G1: a novel uridine diphosphate glycosyltransferase involved in the biosynthesis of picrocrocin, the precursor of safranal in saffronView study →. This makes picrocrocin the glucosylated storage form of the safranal precursor: the plant banks the aroma compound as a stable, water-soluble, bitter glycoside, and hydrolysis later releases the volatile safranal 3,
Ecologically, that bitterness is consistent with a feeding-deterrent role in the stigma, though this is inference from the taste chemistry rather than a demonstrated defence function in the cited work.
Prevalence in Nature
Picrocrocin is, for practical purposes, specific to saffron — the dried stigmas of Crocus sativus — where it is the second-most-abundant apocarotenoid after the crocins 11Reference 11Effective Isolation of Picrocrocin and Crocins from Saffron: From HPTLC to Working Standard ObtainingView study →. It is not a widespread plant metabolite: the biosynthetic machinery (CsCCD2 cleavage of zeaxanthin followed by UGT709G1 glucosylation) is characteristic of Crocus stigma tissue 3Reference 3UGT709G1: a novel uridine diphosphate glycosyltransferase involved in the biosynthesis of picrocrocin, the precursor of safranal in saffronView study →.
Reported contents are high but method- and provenance-dependent. HPTLC quantification across worldwide samples reported picrocrocin at roughly 10–27% of the dried stigma — e.g. ~26.6% in an Iranian sample, ~19.9% Moroccan, ~13.5% Spanish, and ~9.9–24.2% across Ukrainian samples 11Reference 11Effective Isolation of Picrocrocin and Crocins from Saffron: From HPTLC to Working Standard ObtainingView study → — while ISO-style bitterness readings (E¹%₁cm at 257 nm) are used to categorise rather than weigh it, and a large 345-sample survey proposed revising the ISO 3632 category thresholds accordingly 5Reference 5Picrocrocin content and quality categories in different worldwide samples of saffron (Crocus sativus L.)View study →. The headline figure (its rank as saffron’s second major component) is robust; the exact percentage is not a single number.
Discovery & Synthesis
Picrocrocin was identified as saffron’s bitter principle in the early era of saffron chemistry, and its name encodes that discovery — Greek pikros, “bitter”, joined to crocin. A precise first-isolation attribution (author and year) is not well documented in the sources verified here, and is left for a later pass rather than asserted. Its modern structural and analytical characterisation runs through 20th-century chromatography — e.g. HPLC with photodiode-array detection separating picrocrocin, the crocins and safranal in a single run 10Reference 10Separation of picrocrocin, cis-trans-crocins and safranal of saffron using high-performance liquid chromatography with photodiode-array detectionView study → — and LC-ESI-MS surveys of the stigma’s glycosidic apocarotenoids 9Reference 9Crocetin esters, picrocrocin and its related compounds present in Crocus sativus stigmas and Gardenia jasminoides fruitsView study →.
Manufacture today is overwhelmingly extraction from saffron; picrocrocin is isolated from stigma extracts as an analytical/working standard by preparative chromatography (HPTLC) rather than made synthetically 11Reference 11Effective Isolation of Picrocrocin and Crocins from Saffron: From HPTLC to Working Standard ObtainingView study →. Interest in biotechnological production is growing: picrocrocin (with the crocins) has been produced heterologously in Nicotiana benthamiana using a virus-driven system 12Reference 12Efficient production of saffron crocins and picrocrocin in Nicotiana benthamiana using a virus-driven systemView study →, and the biosynthetic genes have been used to engineer saffron apocarotenoids into other hosts — routes aimed at sourcing these expensive molecules without the labour-intensive stigma harvest.
Patents: not yet researched.
Toxicity & Safety
Picrocrocin carries a low flag. It is a dietary constituent of saffron, a spice with a long history of culinary use, and no specific toxicity signal for the isolated compound emerges from the verified literature. The only meaningful cautions are inherited from saffron itself (high doses of the spice can be unsafe) and belong on the herb and product pages, where intake is decided — not on this molecule page.
- Ordinary dietary exposure. Consumed for centuries as a component of saffron at culinary levels, with no isolated-compound toxicity signal identified here.
- Bitterness, not benefit, is the notable effect. Picrocrocin’s defining property in food is taste; its bioactivity is unproven in vivo, so it should not be treated as a supplement in its own right.
- Safety decisions belong to saffron, not the molecule. Dose limits, pregnancy and interaction questions are properties of the whole spice/extract and are addressed on saffron, not here.
- No dedicated toxicology package. No repeat-dose, genotoxicity or reproductive dataset for isolated picrocrocin was located; absence of findings is not evidence of safety.
Dosage
There is no therapeutic or supplemental dose for isolated picrocrocin — it is a flavour and quality-marker compound, not a dosed active. Saffron and its standardised extracts are defined by their apocarotenoid content, with picrocrocin measured as the ISO 3632 bitterness reading (absorbance at 257 nm) rather than delivered as a discrete dose 5Reference 5Picrocrocin content and quality categories in different worldwide samples of saffron (Crocus sativus L.)View study →. Human exposure is entirely dietary, as one component of the spice. Any figures here describe saffron chemistry and are not a personal recommendation.
References
- Kyriakoudi A, et al. (2015). Cellular Transport and Bioactivity of a Major Saffron Apocarotenoid, Picrocrocin. Journal of Agricultural and Food Chemistry. https://pubmed.ncbi.nlm.nih.gov/26340688/
- Chrysanthou A, et al. (2016). Sensory Threshold Studies of Picrocrocin, the Major Bitter Compound of Saffron. Journal of Food Science. https://pubmed.ncbi.nlm.nih.gov/26605534/
- Diretto G, et al. (2019). UGT709G1: a novel uridine diphosphate glycosyltransferase involved in the biosynthesis of picrocrocin, the precursor of safranal in saffron. New Phytologist. https://pubmed.ncbi.nlm.nih.gov/31356694/
- Sánchez AM, et al. (2011). Picrocrocin kinetics in aqueous saffron spice extracts (Crocus sativus L.) upon thermal treatment. Journal of Agricultural and Food Chemistry. https://pubmed.ncbi.nlm.nih.gov/21141822/
- del Campo CP, et al. (2010). Picrocrocin content and quality categories in different worldwide samples of saffron (Crocus sativus L.). Journal of Agricultural and Food Chemistry. https://pubmed.ncbi.nlm.nih.gov/20028014/
- Yu L, et al. (2018). Picrocrocin exhibits growth inhibitory effects against SKMEL-2 human malignant melanoma cells by targeting JAK/STAT5 signaling pathway, cell cycle arrest and mitochondrial mediated apoptosis. Journal of B.U.ON. https://pubmed.ncbi.nlm.nih.gov/30358226/
- Frattaruolo L, et al. (2023). A Picrocrocin-Enriched Fraction from a Saffron Extract Affects Lipid Homeostasis in HepG2 Cells through a Non-Statin-like Mode. International Journal of Molecular Sciences. https://pubmed.ncbi.nlm.nih.gov/36834472/
- Hoshyar R, et al. (2008). Interaction of safranal and picrocrocin with ctDNA and their preferential mechanisms of binding to GC- and AT-rich oligonucleotides. DNA and Cell Biology. https://pubmed.ncbi.nlm.nih.gov/19040376/
- Carmona M, et al. (2006). Crocetin esters, picrocrocin and its related compounds present in Crocus sativus stigmas and Gardenia jasminoides fruits. Journal of Agricultural and Food Chemistry. https://pubmed.ncbi.nlm.nih.gov/16448211/
- Tarantilis PA, et al. (1994). Separation of picrocrocin, cis-trans-crocins and safranal of saffron using high-performance liquid chromatography with photodiode-array detection. Journal of Chromatography A. https://pubmed.ncbi.nlm.nih.gov/8012549/
- Jarukas L, et al. (2022). Effective Isolation of Picrocrocin and Crocins from Saffron: From HPTLC to Working Standard Obtaining. Molecules. https://pubmed.ncbi.nlm.nih.gov/35807531/
- Martí M, et al. (2020). Efficient production of saffron crocins and picrocrocin in Nicotiana benthamiana using a virus-driven system. Metabolic Engineering. https://pubmed.ncbi.nlm.nih.gov/32629020/
